Trial · NCT01760993
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline in Positive and Negative Syndrome Scale (PANSS) Scores at 52 Weeks | Basline and 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| PRIMARY | Change From Baseline in Cognitive Test Battery (CogState Battery) Score at 52 Weeks | Baseline and 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| PRIMARY | Columbia-Suicide Severity Rating Scale (C-SSRS) | Up to 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| PRIMARY | Change From Baseline in Calgary Depression Scale for Schizophrenia (CDSS) at 52 Weeks | Baseline and 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| PRIMARY | Change From Baseline in Simpson Angus Scale (SAS) Total Score at 52 Weeks | Baseline and 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| PRIMARY | Change From Baseline in Barnes Akathisia Scale (BAS) Total Score at 52 Weeks | Baseline and 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| PRIMARY | Change From Baseline in the Abnormal Involuntary Movement Scale (AIMS) at 52 Weeks | Baseline and 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| PRIMARY | Change From Baseline in Clinical Evaluation of Harmful Behavior (CEHB) Scale at 52 Weeks | Baseline and 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| PRIMARY | Change From Baseline in Amphetamine Cessation Symptom Assessment (ACSA) Total Score at 52 Weeks | Baseline and 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| SECONDARY | Change From Baseline in Negative Symptom Assessment (NSA-16) Total Score at 52 Weeks | Baseline and 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| SECONDARY | Change From Baseline in the Personal and Social Performance (PSP) Scale Score at 52 Weeks | Baseline and 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| SECONDARY | Clinical Global Impression-Schizophrenia Severity of Illness (CGI-SCH-S) Scale | Baseline and week 52 | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| SECONDARY | Clinical Global Impression-Schizophrenia Degree of Change (CGI-SCH-C) Scale | Up to 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized | ||
| SECONDARY | Change From Baseline in Social Functioning Scale (SFS) at 52 Weeks | Baseline and 52 weeks | Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01760993/outcomes